Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.
PURPOSE: Preclinical studies have shown that statins reduce proliferation in esophageal cancer. Three recent observational studies have shown encouraging results but suffered from limitations. This work aimed to assess at the Belgian population level whether statin usage was associated with a decreased mortality in esophageal cancer patients. METHODS: We conducted an observational, population-based study by linking data of the Belgian Cancer Registry (BCR) with medical claims data coming from health insurance companies and mortality records collected by regional governments for patients diagno... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2019 |
Verlag/Hrsg.: |
Kluwer Academic Publishers
|
Schlagwörter: | Aged / 80 and over / Belgium / Cohort Studies / Esophageal Neoplasms / Female / Humans / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Male / Middle Aged / Proportional Hazards Models / Registries / Survival / Epidemiology / Esophageal cancer / Pharmacoepidemiology / Statin |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26588150 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/228141 |